Synlett 2014; 25(15): 2139-2142
DOI: 10.1055/s-0034-1378559
letter
© Georg Thieme Verlag Stuttgart · New York

Expedient Assembly of Bioactive Maleic Anhydrides Using Click Diels–Alder Chemistry

John Boukouvalas*
Département de Chimie, Pavillon Alexandre-Vachon, 1045 Avenue de la Médecine, , Université Laval, Quebec City, Quebec, G1V 0A6, Canada   Fax: +1(418)6567916   Email: john.boukouvalas@chm.ulaval.ca
,
Charles Thibault
Département de Chimie, Pavillon Alexandre-Vachon, 1045 Avenue de la Médecine, , Université Laval, Quebec City, Quebec, G1V 0A6, Canada   Fax: +1(418)6567916   Email: john.boukouvalas@chm.ulaval.ca
,
Richard P. Loach
Département de Chimie, Pavillon Alexandre-Vachon, 1045 Avenue de la Médecine, , Université Laval, Quebec City, Quebec, G1V 0A6, Canada   Fax: +1(418)6567916   Email: john.boukouvalas@chm.ulaval.ca
› Author Affiliations
Further Information

Publication History

Received: 19 May 2014

Accepted after revision: 02 July 2014

Publication Date:
11 August 2014 (online)


Abstract

A versatile pathway to substituted maleic anhydrides is illustrated by the synthesis of the nanomolar FTase inhibitor chaetomellic anhydride A, a germination promoter, and a novel bis-­anhydride cross-linking reagent for cell or tissue fixation. Starting from commercial or easily prepared alkynes, these targets were assembled in two steps by click–unclick oxazole–alkyne cycloaddition–cycloreversion and furan oxyfunctionalization.

Supporting Information

 
  • References and Notes

    • 1a Chen X, Zheng Y, Shen Y. Chem. Rev. 2007; 107: 1777
    • 1b Li W, Luo Y, Ju J, Rajski SR, Osada H, Shen B. J. Nat. Prod. 2009; 72: 450
    • 2a Inoue H, Someno T, Kato T, Kumagai H, Kawada M, Ikeda D. J. Antibiot. 2009; 62: 63
    • 2b Phuong DT, Ma C.-M, Hattori M, Jin JS. Phytother. Res. 2009; 23: 582
    • 2c Ndejouong BL. S. T, Sattler I, Maier A, Kelter G, Menzel K.-D, Fiebig H.-H, Hertweck C. J. Antibiot. 2010; 63: 359
    • 2d Nachtigall J, Schulz D, Beil W, Süssmuth RD, Fiedler H.-P. J. Antibiot. 2010; 63: 397
    • 2e Wada S, Usami I, Umezawa Y, Inoue H, Ohba S, Someno T, Kawada M, Ikeda D. Cancer Sci. 2010; 101: 743
    • 3a Stewart SG, Ho LA, Polomska ME, Percival AT, Yeoh GC. T. ChemMedChem 2009; 4: 1657
    • 3b Musso L, Dallavalle S, Farina G, Burrone E. Chem. Biol. Drug Des. 2012; 79: 780
    • 3c Li W, Fan Y, Shen Z, Chen X, Shen Y. J. Pestic. Sci. 2012; 37: 247
  • 4 Singh SB, Zink DL, Liesch JM, Goetz MA, Jenkins RG, Nallin-Omstead M, Silverman KC, Bills GF, Mosley RT, Gibbs JB, Albers-Schonberg G, Lingham RB. Tetrahedron 1993; 49: 5917

    • Syntheses of 1a:
    • 5a Bellesia F, Choi S, Felluga F, Fiscaletti G, Ghelfi F, Menziani MC, Parsons AF, Poulter CD, Roncaglia F, Sabbatini M, Spinelli D. Bioorg. Med. Chem. 2013; 21: 348
    • 5b Kshirsagar UA, Argade NP. Synthesis 2011; 1804
    • 5c Ghelfi F, Pattarozzi M, Roncaglia F, Giangiordano V, Parsons AF. Synth. Commun. 2010; 40: 1040
    • 5d Yoshimitsu T, Arano Y, Kaji T, Ino T, Nagaoka H, Tanaka T. Heterocycles 2009; 77: 179
    • 5e Haval KP, Argade NP. J. Org. Chem. 2008; 73: 6936
    • 5f Bellesia F, Danieli C, De Buyck L, Galeazzi R, Ghelfi F, Mucci A, Orena M, Pagnoni UM, Parsons AF, Roncaglia F. Tetrahedron 2006; 62: 746
    • 5g Takimoto M, Kawamura M, Mori M, Sato Y. Synlett 2005; 2019
    • 5h De Buyck L, Cagnoli R, Ghelfi F, Merighi G, Mucci A, Pagnoni UM, Parsons AF. Synthesis 2004; 1680
    • 5i Kar A, Argade NP. J. Org. Chem. 2002; 57: 7131
    • 5j Singh SB, Jayasuriya H, Silverman KC, Bonfiglio CA, Williamson JM, Lingham RB. Bioorg. Med. Chem. 2000; 8: 571 ; and references cited therein
    • 6a Bell IM. J. Med. Chem. 2004; 47: 1869
    • 6b Ochocki JD, Distefano MD. Med. Chem. Commun. 2013; 4: 476

      Isolation:
    • 7a Mondal G, Dureja P, Sen B. Indian J. Exp. Biol. 2000; 38: 84
    • 7b Weidenmüller H.-L, Cavagna F, Fehlhaber H.-W, Präve P. Tetrahedron Lett. 1972; 3519
    • 7c Almassi F, Ghisalberti EL, Rowland CY. J. Nat. Prod. 1994; 57: 833

    • Syntheses: see ref. 5b,e and:
    • 7d Kar A, Argade NP. Tetrahedron 2003; 59: 2991

      Recent isolation and fungicidal activity:
    • 8a Nakadate S, Nozawa K, Yaguchi T. Mycotoxins 2011; 61: 41

    • Synthesis:
    • 8b Denancé M, Banaszak E, Samadi M. Tetrahedron Lett. 2006; 47: 7409

      Isolation:
    • 9a Weber W, Semar M, Anke T, Bross M, Steglich W. Planta Med. 1992; 58: 56

    • Syntheses:
    • 9b Roncaglia F, Stevens CV, Ghelfi F, Van der Steen M, Pattarozzi M, De Buyck L. Tetrahedron 2009; 65: 1481
    • 9c Mangaleswaran S, Argade NP. J. Org. Chem. 2001; 66: 5259
    • 9d Poigny S, Guyot M, Samadi M. J. Org. Chem. 1998; 63: 1342
    • 10a Brault L, Denancé M, Banaszak E, El Maadidi S, Battaglia E, Bargel D, Samadi M. Eur. J. Med. Chem. 2007; 42: 243
    • 10b Brault L, Bagrel D. Life Sci. 2008; 82: 315

    • See also:
    • 10c Vintonyak VV, Waldmann H, Rauh D. Bioorg. Med. Chem. 2011; 19: 2145
  • 11 Josel H.-P, Gerg M, Herrmann R, Saez Diaz RI. US 20120149019 A1, 2012

    • Recent examples:
    • 12a Hirata Y, Yada A, Morita E, Nakao Y, Hiyama T, Ohashi M, Ogoshi S. J. Am. Chem. Soc. 2010; 132: 10070
    • 12b Deore PS, Argade NP. J. Org. Chem. 2014; 79: 2538
    • 12c Boukouvalas J, Albert V. Heterocycles 2014; 88: 939
    • 12d Basavaiah D, Devendar B, Aravindu K, Veerendhar A. Chem. Eur. J. 2010; 16: 2031
    • 12e Miles WH, Yan M. Tetrahedron Lett. 2010; 51: 1710
    • 12f Boukouvalas J, Albert V, Loach RP, Lafleur-Lambert R. Tetrahedron 2012; 68: 9592
    • 12g Stewart SG, Polomska ME, Lim RW. Tetrahedron Lett. 2007; 48: 2241
    • 12h Cornia A, Felluga F, Frenna V, Ghelfi F, Parsons AF, Pattarozzi M, Roncaglia F, Spinelli D. Tetrahedron 2012; 68: 5863
    • 12i Bae YK, Cho CS. Synlett 2013; 24: 1848
    • 13a Boukouvalas J, Lachance N. Synlett 1998; 31
    • 13b Boukouvalas J, Cheng Y.-X, Robichaud J. J. Org. Chem. 1998; 63: 228
    • 13c Boukouvalas J, Cheng Y.-X. Tetrahedron Lett. 1998; 39: 7025
    • 13d Boukouvalas J, Robichaud J, Maltais F. Synlett 2006; 2480
    • 13e Boukouvalas J, Wang J.-X, Marion O, Ndzi B. J. Org. Chem. 2006; 71: 6670
    • 13f Boukouvalas J, Loach RP. J. Org. Chem. 2008; 73: 8109
    • 13g Boukouvalas J, McCann LC. Tetrahedron Lett. 2011; 52: 1202
    • 13h Boukouvalas J, Loach RP, Ouellet E. Tetrahedron Lett. 2011; 52: 5047
    • 13i Boukouvalas J, Albert V. Tetrahedron Lett. 2012; 53: 3027
    • 13j Boukouvalas J, Jean M.-A. Tetrahedron Lett. 2014; 55: 4248
  • 14 Boukouvalas J, Loach RP. Org. Lett. 2013; 15: 4912
  • 15 Hutton J, Potts B, Southern PF. Synth. Commun. 1979; 9: 789
  • 16 Levin JI, Laakso LM. Oxazole Diels-Alder Reactions, In Oxazoles: Synthesis, Reactions, and Spectroscopy . Palmer DC. Wiley-VCH; Weinheim: 2003. Part A Vol. 60: Chap 3,: 417-472
  • 17 Vogel E, Dörr J, Herrmann A, Lex J, Schmickler H, Walgenbach P, Gisselbrecht JP, Gross M. Angew. Chem., Int. Ed. Engl. 1993; 32: 1597
    • 18a Froborg J, Magnusson G, Thóren S. J. Org. Chem. 1975; 40: 122
    • 18b Mori D, Kimura Y, Kitamura S, Sakagami Y, Yoshioka Y, Shintani T, Okamoto T, Ojika M. J. Org. Chem. 2007; 72: 7190
    • 18c Vlad PF, Ciocarlan A, Edu C, Aricu A, Biriiac A, Coltsa M, D’Ambrosio M, Deleanu C, Nicolescu A, Shova S, Vornicu N, de Groot A. Tetrahedron 2013; 69: 918
    • 19a Tsuboi K, Ichikawa Y, Jiang Y, Naganawa A, Isobe M. Tetrahedron 1997; 53: 5123
    • 19b Shimizu S, Nakamura S, Nakada M, Shibasaki M. Tetrahedron 1996; 52: 13363
    • 20a Ichikawa Y, Tsuboi K, Naganawa A, Isobe M. Synlett 1993; 907
    • 20b Clive DL. J, Sun S. Tetrahedron Lett. 2001; 42: 6267
    • 20c Kimishima A, Hirose T, Sugawara A, Matsumaru T, Nakamura K, Katsuyama K, Toda M, Takada H, Masuma R, Satoshi Ō, Sunazuka T. Tetrahedron Lett. 2012; 53: 2813
  • 21 Data for New Compounds: Heptadec-2-yne (9) FTIR (NaCl, film): 2924, 2854, 1466, 1378, 722 cm–1. 1H NMR (500 MHz, CDCl3): δ = 0.87 (t, J = 7.1 Hz, 3 H), 1.24 (s, 20 H), 1.30–1.38 (m, 2 H), 1.41–1.49 (m, 2 H), 1.75 (t, J = 2.6 Hz, 3 H), 2.07–2.12 (m, 2 H). 13C NMR (100 MHz, CDCl3): δ = 3.5, 14.2, 18.9, 22.9, 29.1, 29.3, 29.4, 29.6, 29.76, 29.84, 29.86, 29.87, 29.89 (2 C), 32.1, 75.3, 79.5. APPI-HRMS: m/z calcd for C17H32 [M*]+: 236.2504; found: 236.2484. 3-Methyl-4-tetradecylfuran (10) FTIR (NaCl, film): 2925, 2854, 1768, 1466, 1143, 1049, 878, 781, 722 cm–1. 1H NMR (400 MHz, CDCl3): δ = 0.89 (t, J = 7.0 Hz, 3 H), 1.22–1.40 (m, 22 H), 1.48–1.58 (m, 2 H), 1.95 (d, J = 1.1 Hz, 3 H), 2.33 (t, J = 7.9 Hz, 2 H), 7.13 (s, 1 H), 7.14 (m, 1 H). 13C NMR (100 MHz, CDCl3): δ = 8.3, 14.3, 22.9, 23.7, 29.50, 29.53, 29.63, 29.65, 29.79, 29.83, 29.84, 29.85 (2 C), 29.87, 32.1, 120.2, 125.8, 139.1, 139.4. ESI-HRMS: m/z calcd for C19H35O [M + H]+: 279.2688; found: 279.2683. 2-(4-Hexylfuran-3-yl)ethanol (12) FTIR (ATR, ZnSe, neat): 3342, 2958, 2930, 2858, 1464, 1049, 790 cm–1. 1H NMR (400 MHz, CDCl3): δ = 0.89 (t, J = 7.1 Hz, 3 H), 1.27–1.39 (m, 6 H), 1.49–1.58 (m, 3 H), 2.34 (t, J = 8.3 Hz, 2 H), 2.64 (t, J = 6.6 Hz, 2 H), 3.77 (t, J = 6.6 Hz, 2 H), 7.17 (s, 1 H), 7.25 (s, 1 H). 13C NMR (100 MHz, CDCl3): δ = 14.2, 22.8, 23.7, 27.1, 29.3, 29.6, 31.8, 62.1, 121.0, 125.4, 139.6, 140.1. ESI-HRMS: m/z calcd for C12H21O2 [M + H]+: 197.1542; found: 197.1528. 1,5-Bis(4-methylfuran-3-yl)pentane (14) FTIR (NaCl, film): 2929, 2857, 1455, 1141, 1047, 876, 783, 597 cm–1. 1H NMR (400 MHz, CDCl3): δ = 1.42–1.51 (m, 2 H), 1.54–1.66 (m, 4 H), 1.99 (d, J = 1.2 Hz, 6 H), 2.38 (t, J = 7.9 Hz, 4 H), 7.15–7.17 (m, 2 H), 7.17–7.19 (m, 2 H). 13C NMR (100 MHz, CDCl3): δ = 8.2, 23.5, 29.27, 29.34, 120.1, 125.6, 139.1, 139.5. ESI-HRMS: m/z calcd for C15H21O2 [M + H]+: 233.1542; found: 233.1526. 3-[5-(4-Methyl-2,5-dioxo-2,5-dihydrofuran-3-yl)pentyl]-4-methylfuran-2,5-dione (5) FTIR (NaCl, film): 2930, 2863, 1761, 1276, 1119, 922, 890, 732 cm–1. 1H NMR (400 MHz, CDCl3): δ = 1.36–1.46 (m, 2 H), 1.58–1.67 (m, 4 H), 2.08 (s, 6 H), 2.46 (t, J = 7.6 Hz, 4 H). 13C NMR (125 MHz, CDCl3): δ = 9.7, 24.3, 27.2, 29.3, 141.0, 144.2, 166.0, 166.2. ESI-HRMS: m/z calcd for C15H17O6 [M + H]+: 293.1025; found: 293.1026. Although 5 is described in a patent,11 characterization data have not been reported.
  • 22 Oxidation of 3-Methyl-4-tetradecylfuran (10) to Chaetomellic Anhydride A (1a) – Typical Procedure Cr2O3 (1.34 g) was weighed in a 5 mL volumetric flask and dissolved in a minimum of nanopure water. Sulfuric acid (aq 98%, 1.15 mL) was cautiously added, and the final volume (5 mL) was adjusted with nanopure water to form the Jones reagent with a concentration of 2.68 M based on CrO3. Furan 10 (47.7 mg, 0.17 mmol, 1.0 equiv) was dissolved in acetone (4.3 mL) in a conical flask (25 mL) and cooled to 0 °C, at which point the Jones reagent (0.32 mL, 0.86 mmol of Cr2O3, 5.05 equiv) was slowly added dropwise under strong agitation. The reaction was stirred at that temperature for 30 min. The temperature was then slowly raised to r.t. After 4 h, the reaction was cooled to 0 °C and quenched with i-PrOH (0.3 mL). The reaction mixture was diluted with H2O (10 mL) and extracted with EtOAc (3 × 15 mL). The organic layers were combined, dried over MgSO4, filtered, and concentrated to yield a yellow oil. Subjection of this oil to flash chromatography on silica gel (gradient of 0–15% hexanes–EtOAc) delivered chaetomellic anhydride A (1a) as a colorless oil (40.3 mg, 76%) that turned into a white waxy solid when stored in the freezer. FTIR (NaCl, film): 2925, 2854, 1768, 1276, 922 cm–1. 1H NMR (400 MHz, CDCl3): δ = 0.88 (t, J = 7.1 Hz, 3 H), 1.20–1.35 (m, 22 H), 1.52–1.61 (m, 2 H), 2.07 (s, 3 H), 2.45 (t, J = 7.8 Hz, 2 H). 13C NMR (100 MHz, CDCl3): δ = 9.7, 14.3, 22.9, 24.6, 27.8, 29.4, 29.5, 29.6 (2 C), 29.72, 29.76, 29.80 (2 C), 29.83, 32.1, 140.6, 144.9, 166.0, 166.4. ESI-HRMS: m/z calcd for C19H33O3 [M + H]+: 309.2430; found: 309.2405.
  • 23 Grossmann K. Pest Manag. Sci. 2010; 66: 113
    • 24a Cantrell CL, Dayan FE, Duke SO. J. Nat. Prod. 2012; 75: 1231
    • 24b Lamberth C, Jeanmart S, Luksch T, Plant A. Science 2013; 341: 742
    • 24c Boukouvalas J, Bruneau-Latour N. Synlett 2013; 24: 2691